U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class Protein
Created
by admin
on Tue Apr 01 22:13:39 GMT 2025
Edited
by admin
on Tue Apr 01 22:13:39 GMT 2025
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1|TOXIN CONJUGATE|KAPPA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
43HH4XYH2N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ENAPOTAMAB VEDOTIN
INN  
Official Name English
AXL-107-MMAE
Preferred Name English
HUMAXAXLADC
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN GROWTH FACTOR RECEPTOR AXL)(HUMAN HUMAX-AXL GAMMA LIGHT CHAIN), DISULFIDE WITH HUMAN HUMAX-AXL KAPPA CHAIN, DIMER, MONOMETHYL AURISTATIN E CONJUGATE
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN GROWTH FACTOR RECEPTOR AXL)(HUMAN HUMAX-AXL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN HUMAX-AXL .KAPPA.-CHAIN, DIMER TETRAKIS(THIOETHER) WITH VEDOTIN
Common Name English
enapotamab vedotin [INN]
Common Name English
HUMAX-AXL-ADC
Code English
Enapotamab vedotin [WHO-DD]
Common Name English
Code System Code Type Description
INN
10769
Created by admin on Tue Apr 01 22:13:39 GMT 2025 , Edited by admin on Tue Apr 01 22:13:39 GMT 2025
PRIMARY
NCI_THESAURUS
C132017
Created by admin on Tue Apr 01 22:13:39 GMT 2025 , Edited by admin on Tue Apr 01 22:13:39 GMT 2025
PRIMARY
SMS_ID
100000181700
Created by admin on Tue Apr 01 22:13:39 GMT 2025 , Edited by admin on Tue Apr 01 22:13:39 GMT 2025
PRIMARY
CAS
1912424-97-5
Created by admin on Tue Apr 01 22:13:39 GMT 2025 , Edited by admin on Tue Apr 01 22:13:39 GMT 2025
PRIMARY
FDA UNII
43HH4XYH2N
Created by admin on Tue Apr 01 22:13:39 GMT 2025 , Edited by admin on Tue Apr 01 22:13:39 GMT 2025
PRIMARY
From To
1_22 1_96
1_143 1_199
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_260 2_320
2_366 2_424
1_219 3_215
1_225 2_225
1_228 2_228
2_219 4_215
3_23 3_89
3_135 3_195
4_23 4_89
4_135 4_195
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
CONJUGATE COMPONENT->CONJUGATE
TARGET->CONJUGATED TOXIN
CONJUGATE COMPONENT->CONJUGATE
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION RESIDUE_SPECIFIC C Amount: Cysteinyl vedotin 6603L01WUR
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL